Amsterdam Molecular Therapeutics
4 clinical trials · Sponsor
◉ Watch Amsterdam Molecular Therapeutics
| Record | Firm | Date |
|---|---|---|
| Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies (NCT01447901) | Amsterdam Molecular Therapeutics | 2011-09-01 |
| Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal "Pancreatitis" Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies (NCT01448577) | Amsterdam Molecular Therapeutics | 2010-11-01 |
| Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects (NCT00891306) | Amsterdam Molecular Therapeutics | 2009-02-01 |
| Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X] (NCT01109498) | Amsterdam Molecular Therapeutics | 2007-08-01 |
Track Amsterdam Molecular Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.